378 related articles for article (PubMed ID: 16859205)
1. Who should be paying for vitamin D analogues--Medicare or the patients?
Hall G
Nephrol Nurs J; 2006; 33(3):345-6, 351. PubMed ID: 16859205
[No Abstract] [Full Text] [Related]
2. Who should be paying for vitamin D analogues--Medicare or the patients?
Grotegut J
Nephrol Nurs J; 2006; 33(3):345-6. PubMed ID: 16912996
[No Abstract] [Full Text] [Related]
3. Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.
Bennett WM
Clin J Am Soc Nephrol; 2010 May; 5(5):743. PubMed ID: 20448072
[No Abstract] [Full Text] [Related]
4. Palliative care in patients with CKD.
Szromba C
Nephrol Nurs J; 2007; 34(5):551-2. PubMed ID: 18041458
[No Abstract] [Full Text] [Related]
5. Vitamin D update. Medicare carrier abandons plan to "ration" i.v. vitamin D in North Carolina, but not South Carolina.
Nephrol News Issues; 2002 Apr; 16(5):55, 58. PubMed ID: 11962152
[No Abstract] [Full Text] [Related]
6. What can we expect down the road?
Sullivan J
Nephrol News Issues; 2011 Apr; 25(4):28-9. PubMed ID: 21542511
[No Abstract] [Full Text] [Related]
7. Important legal, regulatory issues impacting renal care in 2008.
Riley J; Pristave R
Nephrol News Issues; 2008 Dec; 22(13):48-9. PubMed ID: 19149317
[No Abstract] [Full Text] [Related]
8. Erythropoietin & ESRD payments: a promising policy outcome?
Roe W
Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
[No Abstract] [Full Text] [Related]
9. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
Gardner AV
Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
[No Abstract] [Full Text] [Related]
10. A submission from the National Association of Health Underwriters.
Garner JD
J Women Aging; 2010; 22(2):81-2. PubMed ID: 20408029
[No Abstract] [Full Text] [Related]
11. Medicare and erythropoietin.
Steinbrook R
N Engl J Med; 2007 Jan; 356(1):4-6. PubMed ID: 17202449
[No Abstract] [Full Text] [Related]
12. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
13. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
Anantharaman P; Moss AH
Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
[TBL] [Abstract][Full Text] [Related]
14. Is it time for Medicare to provide reimbursement for daily hemodialysis?
Newmann JM
Nephrol News Issues; 2001 Apr; 15(5):57-9. PubMed ID: 12108965
[No Abstract] [Full Text] [Related]
15. Out-of-pocket pharmacy expenditures for veterans under medicare part D.
Rupper RW; Bair BD; Sauer BC; Nebeker JR; Shinogle J; Samore M
Med Care; 2007 Oct; 45(10 Supl 2):S77-80. PubMed ID: 17909387
[TBL] [Abstract][Full Text] [Related]
16. How to make the new Conditions for Coverage work in your dialysis clinic. Patient assessment.
Deziel S; Bodin S
Nephrol News Issues; 2008 Dec; 22(13):38, 40, 42. PubMed ID: 19149316
[No Abstract] [Full Text] [Related]
17. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
Besarab A; McCrea JB
ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
[No Abstract] [Full Text] [Related]
18. Coverage policy for dialysis laboratory tests needs review. RPA. Renal Physicians Association.
Clin Nephrol; 2001 Jun; 55(6):491-2. PubMed ID: 11434365
[No Abstract] [Full Text] [Related]
19. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
Iglehart JK
N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
[No Abstract] [Full Text] [Related]
20. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
